Tianjin Medical Journal ›› 2018, Vol. 46 ›› Issue (10): 1131-1134.doi: 10.11958/20180786

Previous Articles     Next Articles

The progress of miRNA in the pathogenesis of immune thrombocytopenia

ZHAO Hai-feng, KAN Yu-tian, WANG Xin-yuan, ZHANG Yi-zhuo△   

  1. Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin Clinical Research Center for Cancer, Tianjin 300060, China △Corresponding Author E-mail: yizhuozhang111@163.com
  • Received:2018-05-15 Revised:2018-07-15 Published:2018-10-15 Online:2018-11-09

Abstract: Abstract:Immune thrombocytopenia (ITP), one of the most common bleeding disorders, is characterized by clinical manifestations of skin mucosa and internal bleeding and by decreased platelet count due to auto-antibody mediating the platelets destruction and insufficient platelet production. The exact etiology of ITP is still unclear so far. To fully understand the pathogenesis of ITP not only has important theoretical significance but also may provide a new strategy for the treatment of the disease. MicroRNA (miRNA) is a class of small non-coding RNAs with a length of 19-22 nucleotides. It is involved in the occurrence and development of many diseases by regulating its target genes. At present, there are more and more studies on the role of microRNAs in the pathogenesis of ITP. In this review, the progress of miRNA in the pathogenesis of ITP in recent years was summarized

Key words: thrombocytopenia, MicroRNAs, immune thrombocytopenia, review